FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4385778864> ?p ?o ?g. }

• W4385778864 endingPage "1447" @default.
• W4385778864 startingPage "1440" @default.
• W4385778864 abstract "To synthesize the role of secondary cytoreduction in recurrent ovarian cancer from the results of randomized studies.We conducted a meta-analysis of randomized controlled trials which compared secondary cytoreductive surgery versus no surgery in patients with platinum sensitive relapsed ovarian cancer. Individual patient data for overall survival and progression free survival were manually extracted from published survival curves, for whole study populations and subgroups based on completeness of surgical resection and bevacizumab use, using WebPlotDigitizer software. Overall survival and progression free survival curves for each study and the combined population were reconstructed from extracted data.Three studies with 1249 patients were included, of whom complete resection was achieved in 427 (34.2%) patients. In individual patient data analysis of the whole study population with 562 deaths, there was no significant difference in overall survival between the surgery and no surgery groups (median 52.8 vs 52.1 months, respectively, hazard ratio (HR) 0.94, 95% confidence interval (CI) 0.80 to 1.11; p=0.5) but the surgery group had significantly longer progression free survival compared with the no surgery group (median 18.3 vs 14.4 months, respectively, HR 0.70, 95% CI 0.62 to 0.80; p<0.001). In subgroup analyses, overall survival was significantly longer in the complete cytoreduction subgroup compared with the no surgery group (median 62.0 vs 52.1 months, respectively, HR 0.70, 95% CI 0.57 to 0.92; p<0.001) while overall survival was significantly worse in the incomplete cytoreduction subgroup compared with the no surgery group (median 34.2 vs 52.1 months, respectively, HR 1.72, 95% CI 1.38 to 2.14; p<0.001). In the no bevacizumab subgroup, there was no significant overall survival difference between the surgery and no surgery groups (median 49.3 vs 47.0 months, HR 0.86, 95% CI 0.67 to 1.10; p=0.25).Secondary cytoreductive surgery among women with platinum-sensitive relapsed ovarian cancer did not lead to significant benefit in overall survival although it increased progression free survival. However, overall survival was significantly longer among patients in whom complete cytoreduction was possible compared with no surgery." @default.
• W4385778864 created "2023-08-13" @default.
• W4385778864 creator A5011783894 @default.
• W4385778864 creator A5044217179 @default.
• W4385778864 creator A5055543487 @default.
• W4385778864 creator A5058903725 @default.
• W4385778864 creator A5066508788 @default.
• W4385778864 creator A5074723074 @default.
• W4385778864 date "2023-08-11" @default.
• W4385778864 modified "2023-10-06" @default.
• W4385778864 title "Secondary cytoreduction in platinum sensitive relapsed ovarian cancer: an individual patient level meta-analysis" @default.
• W4385778864 cites W1964736695 @default.
• W4385778864 cites W1994741325 @default.
• W4385778864 cites W2038328856 @default.
• W4385778864 cites W2041178952 @default.
• W4385778864 cites W2058708111 @default.
• W4385778864 cites W2077438431 @default.
• W4385778864 cites W2088095316 @default.
• W4385778864 cites W2098923148 @default.
• W4385778864 cites W2110110246 @default.
• W4385778864 cites W2113466571 @default.
• W4385778864 cites W2125435699 @default.
• W4385778864 cites W2135400982 @default.
• W4385778864 cites W2168893449 @default.
• W4385778864 cites W2528228811 @default.
• W4385778864 cites W2563926504 @default.
• W4385778864 cites W2591954457 @default.
• W4385778864 cites W2985168992 @default.
• W4385778864 cites W3080424876 @default.
• W4385778864 cites W3092412842 @default.
• W4385778864 cites W3093048520 @default.
• W4385778864 cites W3135376158 @default.
• W4385778864 cites W3177932018 @default.
• W4385778864 cites W4226453968 @default.
• W4385778864 cites W4236289131 @default.
• W4385778864 cites W4238631637 @default.
• W4385778864 cites W4294236195 @default.
• W4385778864 cites W4308428268 @default.
• W4385778864 cites W4316036672 @default.
• W4385778864 doi "https://doi.org/10.1136/ijgc-2023-004342" @default.
• W4385778864 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37567595" @default.
• W4385778864 hasPublicationYear "2023" @default.
• W4385778864 type Work @default.
• W4385778864 citedByCount "0" @default.
• W4385778864 crossrefType "journal-article" @default.
• W4385778864 hasAuthorship W4385778864A5011783894 @default.
• W4385778864 hasAuthorship W4385778864A5044217179 @default.
• W4385778864 hasAuthorship W4385778864A5055543487 @default.
• W4385778864 hasAuthorship W4385778864A5058903725 @default.
• W4385778864 hasAuthorship W4385778864A5066508788 @default.
• W4385778864 hasAuthorship W4385778864A5074723074 @default.
• W4385778864 hasConcept C121608353 @default.
• W4385778864 hasConcept C126322002 @default.
• W4385778864 hasConcept C141071460 @default.
• W4385778864 hasConcept C143998085 @default.
• W4385778864 hasConcept C168563851 @default.
• W4385778864 hasConcept C187960798 @default.
• W4385778864 hasConcept C207103383 @default.
• W4385778864 hasConcept C2776694085 @default.
• W4385778864 hasConcept C2777802072 @default.
• W4385778864 hasConcept C2780427987 @default.
• W4385778864 hasConcept C2780739268 @default.
• W4385778864 hasConcept C2908647359 @default.
• W4385778864 hasConcept C3019894029 @default.
• W4385778864 hasConcept C44249647 @default.
• W4385778864 hasConcept C71924100 @default.
• W4385778864 hasConcept C95190672 @default.
• W4385778864 hasConcept C99454951 @default.
• W4385778864 hasConceptScore W4385778864C121608353 @default.
• W4385778864 hasConceptScore W4385778864C126322002 @default.
• W4385778864 hasConceptScore W4385778864C141071460 @default.
• W4385778864 hasConceptScore W4385778864C143998085 @default.
• W4385778864 hasConceptScore W4385778864C168563851 @default.
• W4385778864 hasConceptScore W4385778864C187960798 @default.
• W4385778864 hasConceptScore W4385778864C207103383 @default.
• W4385778864 hasConceptScore W4385778864C2776694085 @default.
• W4385778864 hasConceptScore W4385778864C2777802072 @default.
• W4385778864 hasConceptScore W4385778864C2780427987 @default.
• W4385778864 hasConceptScore W4385778864C2780739268 @default.
• W4385778864 hasConceptScore W4385778864C2908647359 @default.
• W4385778864 hasConceptScore W4385778864C3019894029 @default.
• W4385778864 hasConceptScore W4385778864C44249647 @default.
• W4385778864 hasConceptScore W4385778864C71924100 @default.
• W4385778864 hasConceptScore W4385778864C95190672 @default.
• W4385778864 hasConceptScore W4385778864C99454951 @default.
• W4385778864 hasIssue "9" @default.
• W4385778864 hasLocation W43857788641 @default.
• W4385778864 hasLocation W43857788642 @default.
• W4385778864 hasOpenAccess W4385778864 @default.
• W4385778864 hasPrimaryLocation W43857788641 @default.
• W4385778864 hasRelatedWork W2006600283 @default.
• W4385778864 hasRelatedWork W2167750533 @default.
• W4385778864 hasRelatedWork W2171714209 @default.
• W4385778864 hasRelatedWork W2333764022 @default.
• W4385778864 hasRelatedWork W2413916090 @default.
• W4385778864 hasRelatedWork W2584409920 @default.
• W4385778864 hasRelatedWork W2887267288 @default.
• W4385778864 hasRelatedWork W2974266924 @default.

• next